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IntroDuctIon
Vitamin D is a secosteroid existing in two major forms: 
ergocalciferol and cholecalciferol. The most recognized function 
of this vitamin is in maintenance of calcium homeostasis.1 
However more recent evidence supports a role of vitamin 
D in brain development and function, in regulation of 
insulin production, in controlling immune responses and in 
cardiovascular and musculoskeletal health.2
1. VItaMIn D anD Its MoDulatorY functIon 
a. the nerVous sYsteM
Vitamin D alters the synthesis and secretion of neurotrophic 
factors, nerve growth factors and the neurotrophin receptor 
p75NTR. Its deficit results in decreased expression of 
neurotrophins and p75NTR, leading to a loss of the survival, 
differentiation and maintenance function that these exert in 
nerve cells, contributing to neurodegeneration.3
By interacting with and reducing reactive oxidative species 
(ROS), vitamin D prevents oxidative stress-induced neuronal 
damage. Even nanomolar concentrations of vitamin D (0.1-100 
nM) help to protect neurons from such damage.4 Vitamin D 
inhibits γ-glutamyl transpeptidase and nitric oxide synthase. 
This leads to lower levels of intracellular hydrogen peroxide and 
nitric oxide respectively, further exerting anti-oxidant effects.5
Vitamin D is also involved in sustaining intracellular calcium 
ion (Ca2+) homeostasis by suppressing L-type Ca2+ channels. 
Physiologically elevated levels of Ca2+ ions in the cytosol lead to 
exocytosis of various stimulating amino acids neurotransmitters, 
resulting in excitotoxicity.5 
b. the IMMune sYsteM
Inhibition of memory- and plasma- cell production, as well 
as promotion of apoptosis of B-lymphocytes are direct effects 
exerted by vitamin D on B-cells. By controlling B-lymphocyte 
activation and proliferation, vitamin D reduces the production 
of autoantibodies, which are involved in the pathophysiology of 
autoimmune disorders.5 
Vitamin D suppresses T helper cell (Th) proliferation 
and differentiation. Through down regulation of the major 
histocompatibility complex-II (MHC-II) antigen and the 
production of interleukin (IL)-23 and IL-12, vitamin D shifts 
the polarization of T-lymphocytes from a Th17 and Th1 
phenotype towards a Th2 phenotype. This results in reduced 
production of pro-inflammatory cytokines like IL-17 and 
interferon-γ and promotes the synthesis of anti-inflammatory 
Th2 cytokines, including IL-3 and IL-10. By suppressing 
dendritic cell survival, vitamin D further promotes the 
development of T regulatory cells and Th2 cells.6 
Lucas et al.7 have shown that vitamin D helps in 
maintaining the ratio of activated Th1/Th17 cells in the 
systemic circulation and prevents their movement across 
the blood-brain barrier. This reduces the expression of the 
chemokine receptor CXCR3. Increased expression of this 
receptor increases intracellular Ca2+ levels by activating the 
phosphoinositide 3-kinase (PI3K) and mitogen-activated 
protein kinase pathways, leading to excitotoxicity.8
Another target through which vitamin D mediates 
suppression of self-reactive T-lymphocytes is the Fas ligand. 
The Fas-FasL pathway regulates activation-induced cell death 
in T-lymphocytes, thereby maintaining central and peripheral 
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tolerance to self-antigens. Through downregulation of this 
ligand vitamin D alters the immune response at various levels, 
preventing the development of autoimmune diseases.9
This shows that vitamin D is an environmental factor, related 
to both autoimmune and neurodegenerative disorders. In fact, 
studies suggest that hypovitaminosis D, which is defined as a 
vitamin D serum concentration of being less then 25nmol/L, 
negatively impacts such disorders.10 
2. VItaMIn D anD autoIMMunItY 
With insufficient vitamin D serum levels, the immune system 
allows the up-regulation of B-cells and self-reactive T-cells. The 
production of inflammatory cytokines, together with increased 
production of immunoglobulin producing B-cells, contributes to 
the development of autoimmune diseases.11
Vitamin D deficiency has also been implicated in facilitating the 
progression of existing autoimmune disorders. In a study carried 
out by Zold et al.12 161 patients with an early connective tissue 
disorder were followed for about 2 years. There was no progression 
of the disease in most of the patients. However 21% of the patients 
developed a specific rheumatologic disorder including systemic 
lupus erythematous (SLE). Lower vitamin D levels were present in 
the population in which the disease progressed to a definitive state.12
Hypovitaminosis D is linked to several autoimmune 
disorders, including multiple sclerosis (MS), type 1 diabetes 
mellitus (T1DM) and inflammatory bowel disease (IBD).5 MS is 
the only autoimmune disease in which the effects of vitamin D 
have been well-established. 
a. MultIple sclerosIs
MS is an autoimmune neurodegenerative disease, driven 
by myelin auto-reactive T- lymphocytes, which leads to 
the recruitment of macrophages, with subsequent myelin 
destruction and axon degeneration.5 
Vitamin D deficiency leads to loss of balance between the 
inflammatory and anti-inflammatory pathways. This is because 
activation of immature dendritic cells results in mature dendritic cell 
production, leading to reduced differentiation of immunosuppressive 
regulatory T-cells and increase in Th1 cells. These synthesize and 
secrete inflammatory cytokines, including IL-23 and interferon-γ, 
leading to demyelination. Prolonged toxic insults to neurons results 
in the release of neural antigens, stimulating further inflammatory 
responses, enhancing demyelination .13 
Vitamin D acts as a specific inhibitor of osteopontin, a 
pro-inflammatory cytokine involved in the progression of 
MS. Osteopontin increases the production of IL-12, tumor 
necrosis factor and interferon-γ by T-lymphocytes, inhibits 
IL-10 production and lengthens the life-span of activated 
T-lymphocytes. In fact, higher levels of osteopontin transcripts 
are found in patients suffering from MS.5 
In utero levels of vitamin D also affect the risk of development 
MS later in life. Eyles et al. 14 showed that in utero vitamin D 
deficiency led to the dysregulation of various mRNA transcripts, 
including the enzyme calcineurin and FK506 binding protein 1a in 
the brain tissue of the offspring. These function to limit the synthesis 
of IL-2, which results in cytotoxic T-cell activation and tissue damage.
Genetic Risk Factors 
Vitamin D receptor gene
The FokI polymorphism of the vitamin D receptor (VDR) gene 
affects in vitro vitamin D-mediated inhibition of IL-12 transcription 
and protein production by dendritic cells and monocytes. IL-12 
induces Th1 cells, contributing to neuronal inflammation.15 The 
TaqI variant of the VDR gene is also weakly related to MS.16 
HLA-DRB1 gene
The MHC gene on chromosome 6 provides the single largest 
contribution to disease susceptibility in the entire genome. The 
classical human leukocyte antigen (HLA)-DRB1*15:01 allele 
has been documented as the strongest genetic association to 
the risk of developing MS.17 The vitamin D response element in 
the HLA-DRB1 promoter, corresponding to the HLA-DRB1*15 
haplotype, binds VDR with higher affinity than other elements. 
Vitamin D stimulation of B-lymphocytes transfected with HLA-
DRB1 gene constructs, including the HLA-DRB1*15 sequence, 
doubles the expression of HLA-DRB1*15:01. This suggests that 
the HLA-DRB1*15:01 haplotype greatly contributes to the effect 
exerted by vitamin D in MS.18 A lack of vitamin D during the 
early life of HLA-DRB1*15-bearing individuals could allow 
autoreactive T-cells to escape thymic deletion, increasing the 
risk of the development of autoimmune disorders.19
Epigenetic changes in the genes encoding cytochrome 
P450 reductase (CYP) 27B1 and CYP24A1, which are 
involved in vitamin D metabolism and catabolism 
respectively, also affect vitamin D serum levels, contributing 
to the pathogenesis of the disease.17
b. other autoIMMune DIsorDers
i. Type 1 Diabetes Mellitus
T1DM results from immune-mediated destruction of 
β-pancreatic cells. Apart from acting at a peripheral level and 
controlling the cellular-mediated pathogenesis of this disease, 
vitamin D reduces the selection of self-reactive T-cells in the 
thymus.20 Vitamin D supplementation also decreases the risk of 
developing T1DM. In a study21 involving 10,366 children carried 
out in Finland, daily supplementation of 2000IU of vitamin D in 
the first year of life reduced the risk of developing T1DM in the 
next 31 years by about 80%.21
ii. Inflammatory Bowel Disease
IBD includes ulcerative colitis and Crohn’s disease, both of which 
are characterized by chronic inflammation of the intestine. Reduced 
levels and/or dysfunctional auto-phagocytosis have been implicated 
as contributing factors in IBD.22 By enhancing the co-localization 
of pathogen-harboring phagosomes with autophagosomes in a 
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cathelicidin-dependent manner, vitamin D increases the basal levels 
of autophagy.23 Vitamin D down-regulates the expression of the 
protein kinase mammalian target of rapamycin (mTOR), a negative 
regulator of autophagy.24 Furthermore, through the activation of 
the PI3K signaling pathway, it enhances beclin-1 expression, which 
stimulates auto-phagocytic processes.23
3. VItaMIn D anD neuroDegeneratIon 
Insufficient levels of vitamin D results in increased levels of Ca2+ 
ions and ROS, which together with reduced neurotrophin levels, 
contribute to neuronal degeneration. Hypovitaminosis D also 
contributes to immune-mediated degeneration. Interactions between 
Th1, Th17 cells and inflammatory cytokines result in microglia 
activation and inflammation, resulting in cytotoxicity and neuronal 
damage.5 Apart from MS, low levels of vitamin D are linked to several 
neurodegenerative disorders including amyotrophic lateral sclerosis 
(ALS) and Alzheimer’s dementia (AD).5,25 
a. aMYotrophIc lateral sclerosIs
Multiple effector pathways contribute to ALS pathology 
including deficiency of neurotrophic factors, glutamate toxicity 
and damage from ROS, all of which are kept in control by 
vitamin D. An abnormal calcium-parathyroid hormone-vitamin 
D level has been detected in patients with ALS, with vitamin D 
serum concentrations being significantly lower in ALS patients 
than in transgenic mouse control models of ALS. Such patients 
showed improvements in their functional capacity following 
dietary vitamin D supplementation.25
Several of the ALS susceptibility genes with related 
VDR-binding sites have been indicated in salient brain 
functions such as neuritogenesis and axonal growth.26 In 
fact, the Gc2 polymorphism of vitamin D-binding protein 
was recorded in the plasma of a cohort of Portuguese 
patients with familial ALS.27 
b. alzheIMer’s DeMentIa
Given the role of vitamin D in facilitating neurotransmitter 
synthesis, protecting against oxidative stress, reducing 
pro-inflammatory responses, and maintaining neurite 
outgrowth,5 a biological basis exists that supports the role of 
vitamin D in the pathogenesis of cognitive impairment and 
AD. 72% of the 25 cross-sectional studies analyzed by van der 
Schaft et al. report a statistically significant worse outcome 
on one or more cognitive function tests or a higher frequency 
of dementia with lower vitamin D levels or intake. 66.7% 
prospective studies show a higher risk of cognitive decline 
after a follow-up period of 4–7 years in participants with 
lower vitamin D levels at baseline.28 
conclusIon 
Vitamin D exhibits the main characteristics of a true neuroactive 
steroid, with clinical and experimental evidence that vitamin 
D deficiency is an important factor involved in autoimmune 
and neurodegenerative disorders. However little is still known 
whether its supplementation helps in the prevention and 
treatment of such disorders. 
references
1. Verstuyf A, Carmeliet G, Bouillon R, et al. Vitamin D: a pleiotropic hormone. 
Kidney Int 2010;78(2):140-145.
2. Makariou S, Liberopoulos EN, Elisaf M, et al. Novel roles of vitamin D in disease: 
what is new in 2011? Eur J Intern Med 2011;22(4):355-362.
3. Smolders J, Moen SM, Damoiseaux J, et al. Vitamin D in the healthy and inflamed 
central nervous system: access and function. J Neurol Sci 2011;311(1):37-43.
4. Kalueff A, Eremin K, Tuohimaa P. Mechanisms of neuroprotective action of 
vitamin D3. Biochemistry (Moscow) 2004;69(7):738-741.
5. de Abreu DF, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: 
implications for neurodegenerative and autoimmune diseases. 
Psychoneuroendocrinology 2009;34:S265-S277.
6. Cantorna M. Mechanisms underlying the effect of vitamin D on the immune 
system. Proc Nutr Soc 2010;69:286-289.
7. Lucas R, Gorman S, Geldenhuys S, et al. Vitamin D and immunity. F1000prime 
reports 2010;6. 
8. Grishkan IV, Fairchild AN, Calabresi PA, et al. 1,25-Dihydroxyvitamin D3 
selectively and reversibly impairs T helper-cell CNS localization. Proc Natl Acad 
Sci U S A 2013;110(52):21101-21106.
9. Baeke F, Van Etten E, Overbergh L, et al. Vitamin D 3 and the immune system: 
Maintaining the balance in health and disease. Nutrition research reviews 
2007;20(1):106-118.
10. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune 
system: modulation of innate and autoimmunity. Journal of Molecular Medicine 
2010;88(5):441-450.
11. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological 
and therapeutic considerations. Ann Rheum Dis 2007;66(9):1137-1142.
12. Zold E, Szodoray P, Gaal J, et al. Vitamin D deficiency in undifferentiated 
connective tissue disease. Arthritis research & therapy 2008;10(5):R123.
13. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, 
inflammation, and neurodegeneration. Neuron 2006;52(1):61-76.
14. Eyles D, Almeras L, Benech P, et al. Developmental vitamin D deficiency 
alters the expression of genes encoding mitochondrial, cytoskeletal 
and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol 
2007;103(3):538-545.
15. van Etten E, Verlinden L, Giulietti A, et al. The vitamin D receptor gene FokI 
polymorphism: functional impact on the immune system. Eur J Immunol 
2007;37(2):395-405.
16. Cox MB, Ban M, Bowden NA, et al. Potential association of vitamin D receptor 
polymorphism Taq1 with multiple sclerosis. Mult Scler 2012(1):16-22.
17. Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role 
for cell-mediated immune mechanisms in multiple sclerosis. Nature 
2011;476(7359):214-219.
18. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple 
sclerosis-associated MHC class II Allele HLA-DRB1* 1501 is regulated by vitamin 
D. PLoS genetics 2009;5(2):e1000369.
19. Yu S, Cantorna MT. The vitamin D receptor is required for iNKT cell 
development. Proc Natl Acad Sci U S A 2008;105(13):5207-5212.
20. Decallonne B, van Etten E, Overbergh L, et al. 1α, 25-Dihydroxyvitamin D 3 
restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice 
through dendritic cells. J Autoimmun 2005;24(4):281-289.
21. Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin 
D genes is associated with predisposition to autoimmune disease type 1 
diabetes. Diabetes 2011;60(5):1624-1631.
22. El-Khider F, McDonald C. Links of Autophagy Dysfunction to Inflammatory 
Bowel Disease Onset. Dig Dis 2016;34(1-2):27-34.
23. Yuk J, Shin D, Lee H, et al. Vitamin D3 induces autophagy in human monocytes/
macrophages via cathelicidin. Cell host & microbe 2009;6(3):231-243.
24. Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation 
and infection. Discov Med 2011;11(59):325-335.
25. Long K, Nguyen LT. Roles of vitamin D in amyotrophic lateral sclerosis: possible 
genetic and cellular signalling mechanisms. Mol Brain 2013;6:16-6606-6-16.
26. Stadelmann C, Wegner C, Brück W. Inflammation, demyelination, and 
degeneration—recent insights from MS pathology. Biochimica et Biophysica Acta 
(BBA)-Molecular Basis of Disease 2011;1812(2):275-282.
27. Palma AS, De Carvalho M, Grammel N, et al. Proteomic analysis of plasma from 
Portuguese patients with familial amyotrophic lateral sclerosis. Amyotrophic Lat 
Scler 2008;9(6):339-349.
28. Van der Schaft J, Koek H, et al. The association between vitamin D and cognition: 
a systematic review. Ageing research reviews 2013;12(4):1013-1023.
8 Volume 17, 2018  issue 03
